Condition: Osteoarthritis, Knee · Sponsor: R3 Medical Research
This is a Pilot Study which is randomized, prospective, open label, dose escalation, non-controlled evaluating safety and feasibility of intra-articular Wharton's Jelly (WJ) allograft will be evaluated in patients suffering with knee osteoarthritis. The participants will be randomized to one of three dosing treatment arms that will consist of one intra-articular knee injection containing either low dose, medium dose or high dose WJ allograft tissue.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| R3 Anti Aging Scottsdale | Scottsdale, Arizona, United States | Recruiting |
| R3 Anti Aging Beverly Hills | Beverly Hills, California, United States | Recruiting |
| Optimal Medical Group | Fresno, California, United States | Recruiting |
| Scheer Medical Wellness | New York, New York, United States | Recruiting |
| Dr. Duc (Steve) Le, MD | Cleveland, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06608134